| Hans-Günter Meyer-Thompson | Naltrexon
Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder.
Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder.
Shi Z, Li X, Kampman KM, Childress AR, Wiers CE, Langleben DD.
J Clin Psychiatry. 2023 Apr 17;84(3):22br14567. doi: 10.4088/JCP.22br14567. PMID: 37074295; PMCID: PMC10119768.
https://www.psychiatrist.com/jcp/addiction/depression-cue-reactivity-in-opioid-use-disorder-during-naltrexone-xr-treatment/